Commercial Access Only
Specimen SS-COM-AST-0352 // ASTRINGENCY
Grape Extract T3-PR-PH
Vitis vinifera
Grape
Grape Extract SeriesTier 3
Target Trait
600
mg/L
Reported target: 600 mg/L proanthocyanidin
Technical Specifications
Genomic Edits
10
GC Content
(52%)
Construct Length
7,450 bp
Promoter System
Ubiquitin / T7
Expression System
Protoplast PEG-fusion
Host Strain
PEG-mediated
Pathway Edits
- LAR/ANR dual expression
- Anthocyanidin reductase upregulation
- Flavonoid flux enhancement
Key Interventions
Flavonoid flux redirection via MYB transcription factorANR-driven epiafzelechin accumulation
Application Domains
PharmaceuticalResearch
Intended Use
High-purity grape tannin extract for pharmaceutical-grade astringency compounds — Pharmaceutical, Research grade via protoplast peg-fusion.
Access
Request Commercial Access
This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.
Contact Us →No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.